Test Price
2,800 AEDโ Home Collection Available
SLC35D1 Gene Sequencing for Schneckenbecken Dysplasia (NGS) in UAE | 2800 AED
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO 9001:2015 accredited processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
- Clinical Guidance: Telephonic post-test clinical guidance in result interpretation by DHA-licensed specialists.
- Insurance: Direct billing verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
This advanced genetic test uses next-generation sequencing (NGS) to analyze the SLC35D1 gene for mutations causing Schneckenbecken dysplasia, a rare skeletal disorder. It provides a definitive molecular diagnosis for symptomatic patients, offering exceptional analytical sensitivity for single nucleotide variants, indels, and copy number changes.
| Feature | Our Test (NGS โ SLC35D1) | Alternative (Single-Gene Sanger) |
|---|---|---|
| Precision | >99.9% analytical sensitivity for SNVs, indels, and CNVs | Limited to known point mutations; misses large deletions |
| Methodology | Massively parallel sequencing with full bioinformatic annotation | Sanger sequencing of select exons |
| Turnaround | 3โ4 weeks | 6โ8 weeks (if custom primers required) |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh (Consultant Medical Genetics, DHA ID: 9294403): โSchneckenbecken dysplasia is an ultra-rare autosomal recessive skeletal dysplasia often lethal in the perinatal period. Definitive molecular confirmation via NGS enables accurate genetic counseling, recurrence risk assessment, and informed reproductive decisions. All positive results require correlation with clinical and radiographic findings, and post-test counseling is mandatory.โ
Pre-Test Advisory & Safety Considerations
Medication and Clinical Precautions
Do not discontinue any prescribed medication without consulting your physician. Heparin-containing anticoagulants should be withheld 24 hours prior to blood draw to avoid sample interference. No specific drug interactions are known for the genetic analysis itself, but clinical correlation remains essential.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Samples contaminated with other nucleic acids, insufficient volume, or collected in heparin tubes will be rejected. Patients with a confirmed benign variant in SLC35D1 should not be retested.
- Emergency Red Flags (seek immediate medical attention): Newborn respiratory distress, severe limb shortening detected on prenatal ultrasound, or recurrent pregnancy loss suggestive of lethal skeletal dysplasia. These are not test complications but indicators of underlying severe disease.
- Minors: This test is performed only with legally authorized guardian consent in compliance with Federal Decree-Law No. 4 of 2016 on Medical Liability.
Patient FAQ & Clinical Guidance
1. What does the SLC35D1 NGS test detect and how accurate is it?
This test detects single nucleotide variants, small insertions/deletions, and copy number changes in the SLC35D1 gene with over 99.9% diagnostic sensitivity, providing molecular confirmation of Schneckenbecken dysplasia when clinical suspicion is high.
2. How is the sample collected and what is the turnaround time?
A DHA-certified phlebotomist collects a small blood sample (EDTA tube) or a few drops on an FTA card via our VIP Mobile Phlebotomy service. Results are delivered securely within 3 to 4 weeks after lab receipt of the specimen.
3. Will my insurance cover this genetic test in the UAE?
Coverage varies by policy. We offer direct insurance billing verification via WhatsApp at +971 54 548 8731; send your policy details and we confirm eligibility before any cost is incurred.
UAE Regulatory & Data Privacy Adherence
Data Protection: All genetic data is handled in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient information is encrypted, access-restricted, and destroyed per regulatory timelines.
ISO Accreditation: ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | SLC35D1 Gene Sequencing for Schneckenbecken Dysplasia (NGS) |
| Price (AED) | 2800 |
| Turnaround Time | 3โ4 weeks |
| Sample Type / Matrix | Whole Blood (EDTA), Extracted DNA, or FTA Card |
| Methodology Used | Next-Generation Sequencing (NGS) with full bioinformatic annotation |
| ICD-10-CM Code | Q77.8 (Osteochondrodysplasia), Z13.8 (Screening), Z84.8 (Family history) |
| LOINC Code | 103304-4 |
| DHA Facility License & Laboratory Address | License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians